Medicamen Biotech Limited Total Assets

Latest as of March 2026: Rs3.72 Billion INR ≈ $40.23 Million USD

Medicamen Biotech Limited total assets. Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) holds total assets worth Rs3.72 Billion INR (≈ $40.23 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Medicamen Biotech Limited stock valuation for the company's overall valuation and market capitalisation.

Total Assets of Medicamen Biotech Limited (2006–2026)

Total assets of Medicamen Biotech Limited from 2006 to 2026. This chart illustrates how Medicamen Biotech Limited's total assets have evolved over time, based on quarterly financial data. See Medicamen Biotech Limited stock quote for real-time trading data and today's change.

Medicamen Biotech Limited - Asset Composition Analysis

Medicamen Biotech Limited Total Assets Breakdown (March 2026)

Medicamen Biotech Limited total assets breakdown as of March 2026. Medicamen Biotech Limited's total assets of Rs3.72 Billion consist of 60.2% current assets and 39.9% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	8.4%
Accounts Receivable	Rs818.28 Million	22.0%
Inventory	Rs700.79 Million	18.8%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs5.72 Million	0.2%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2006–2026)

This chart illustrates how Medicamen Biotech Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Medicamen Biotech Limited (MEDICAMEQ) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Medicamen Biotech Limited's current assets represent 60.2% of total assets in 2026, a decrease from 68.2% in 2006.
Cash Position: Cash and equivalents constituted 8.4% of total assets in 2026, up from 0.4% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 22.0% of total assets.

Medicamen Biotech Limited Competitors by Total Assets

Key competitors of Medicamen Biotech Limited based on total assets are shown below.

Company	Country	Total Assets
Jiangsu Hengrui Medicine Co Ltd SHG:600276	China	CN¥68.33 Billion
Sandoz Group AG SW:SDZ	Switzerland	CHF22.86 Billion
H Lundbeck A/S CO:HLUN-B	Denmark	Dkr54.01 Billion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Viyash Scientific Limited NSE:SEQUENT	India	Rs17.26 Billion
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	China	CN¥5.11 Billion

Medicamen Biotech Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.54	2.11	1.80
Quick Ratio	1.75	1.31	1.70
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs1.36 Billion	Rs863.84 Million	Rs427.59 Million

Medicamen Biotech Limited - Advanced Valuation Insights

This section examines the relationship between Medicamen Biotech Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.59
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	25.3%
Total Assets	Rs3.72 Billion
Market Capitalization	$38.60 Million USD

Valuation Analysis

Below Book Valuation: The market values Medicamen Biotech Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Medicamen Biotech Limited's assets grew by 25.3% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Medicamen Biotech Limited (2006–2026)

The table below shows the annual total assets of Medicamen Biotech Limited from 2006 to 2026.

Year	Total Assets	Change
2026-03-31	Rs3.72 Billion ≈ $40.23 Million	+25.30%
2025-03-31	Rs2.97 Billion ≈ $32.11 Million	+0.79%
2024-03-31	Rs2.95 Billion ≈ $31.85 Million	+5.76%
2023-03-31	Rs2.79 Billion ≈ $30.12 Million	+23.41%
2022-03-31	Rs2.26 Billion ≈ $24.41 Million	+16.33%
2021-03-31	Rs1.94 Billion ≈ $20.98 Million	+7.02%
2020-03-31	Rs1.81 Billion ≈ $19.61 Million	+32.72%
2019-03-31	Rs1.37 Billion ≈ $14.77 Million	+16.20%
2018-03-31	Rs1.18 Billion ≈ $12.71 Million	+60.15%
2017-03-31	Rs734.01 Million ≈ $7.94 Million	+22.30%
2016-03-31	Rs600.18 Million ≈ $6.49 Million	-12.59%
2015-03-31	Rs686.63 Million ≈ $7.43 Million	+6.32%
2014-03-31	Rs645.79 Million ≈ $6.98 Million	-1.00%
2013-03-31	Rs652.34 Million ≈ $7.05 Million	-5.33%
2012-03-31	Rs689.07 Million ≈ $7.45 Million	-1.59%
2011-03-31	Rs700.18 Million ≈ $7.57 Million	+21.38%
2010-03-31	Rs576.83 Million ≈ $6.24 Million	+25.92%
2009-03-31	Rs458.11 Million ≈ $4.95 Million	-11.51%
2008-03-31	Rs517.72 Million ≈ $5.60 Million	+11.54%
2007-03-31	Rs464.17 Million ≈ $5.02 Million	+37.25%
2006-03-31	Rs338.18 Million ≈ $3.66 Million	--

About Medicamen Biotech Limited

NSE:MEDICAMEQ India Drug Manufacturers - Specialty & Generic

Market Cap

$38.60 Million

Rs3.57 Billion INR

Market Cap Rank

#22646 Global

#1250 in India

Share Price

Rs263.15

Change (1 day)

+0.38%

52-Week Range

Rs219.88 - Rs415.95

All Time High

Rs1195.88